Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0232 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_0232 |
| Peptide Name | NA |
| PEPTIDE SEQUENCE (1-letter) | RGD |
| PEPTIDE SEQUENCE (3-letter) | ArgGlyAsp |
| N-terminal modification | NA |
| C-terminal modification | NA |
| Chemical modification | NA |
| Peptide Length | 3 |
| Conformation | Linear |
| Peptide Nature | Cationic |
| Source/Origin of peptide | Chemically synthesized |
| SMILES | NA |
| Cell Line | NA |
| In vitro CONCENTRATION | NA |
| In vitro METHOD | NA |
| In vitro RESULT | NA |
| ANIMAL MODEL | BALB/c mice xenograft for U87MG glioma cells |
| In vivo CONCENTRATION | 5mg/Kg |
| In vivo MODE OF DELIVERY | Intravenous |
| In vivo METHOD | Fluoroscent measurement |
| In vivo RESULT | Significant amount of drugsa delivered in brain tissue |
| ACTION | Peptide can deliver drugs into brain tissue |
| TRANSPORT TYPE | NA |
| SUBCELLULAR LOCALISATION | NA |
| COMBINATION | Doxorubicin+paclitaxel in 5mg/Kg combination |
| PHYSICAL CONDITION | Brain glioma therapy |
| RESPONSE | NA |
| RESULT | NA |
| LABEL | NA |
| PMID | 27143884 |